HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.

AbstractOBJECTIVE:
We investigated the agreement between the tuberculin skin test (TST) and the QuantiFERON-TB gold (QFT-G) assay in the diagnosis of latent tuberculosis infection (LTBI) in patients with systemic lupus erythematosus (SLE). Furthermore, we evaluated the factors associated with indeterminate results in the QFT-G assay in patients with SLE.
METHODS:
We enrolled 136 patients with SLE prospectively, and compared them to 66 patients with rheumatoid arthritis (RA). In addition to the TST, QFT-G assay, patients' medications, and Bacillus Calmette-Guérin (BCG) vaccination status were also investigated. A positive TST or QFT-G assay result without an active tuberculosis lesion on chest x-ray was considered to indicate a diagnosis of LTBI.
RESULTS:
The prevalence of LTBI was 26.5% in patients with SLE and 30.3% in patients with RA. The agreement between the TST and QFT-G assay was fair in SLE patients, but poor in RA patients. BCG vaccination was one factor associated with discordance between TST and QFT-G. Older age and higher SLE Disease Activity Index (SLEDAI) score were associated with a negative TST/positive QFT-G result in patients with SLE. Higher SLEDAI score and increased glucocorticoid dose were associated with an indeterminate result in the QFT-G assay for patients with SLE.
CONCLUSIONS:
Agreement between the QFT-G assay and TST in patients with SLE was found to be fair. However, BCG vaccination status, age, and SLEDAI score are all factors that could result in discordance between the two tests. Indeterminate results from the QFT-G assay may be caused by a higher SLEDAI score or increased glucocorticoid dose.
AuthorsH Cho, Y W Kim, C-H Suh, J-Y Jung, Y-J Um, J-H Jung, H-A Kim
JournalLupus (Lupus) Vol. 25 Issue 12 Pg. 1341-8 (Oct 2016) ISSN: 1477-0962 [Electronic] England
PMID26985011 (Publication Type: Comparative Study, Journal Article)
Copyright© The Author(s) 2016.
Chemical References
  • Glucocorticoids
Topics
  • Adult
  • Age Factors
  • Arthritis, Rheumatoid (diagnosis, immunology)
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Interferon-gamma Release Tests (methods)
  • Latent Tuberculosis (diagnosis, epidemiology)
  • Lupus Erythematosus, Systemic (drug therapy, immunology, microbiology)
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Sensitivity and Specificity
  • Tuberculin Test (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: